OnKure Therapeutics Inc (NASDAQ: OKUR) open the trading on Thursday, with great promise as it jumped 12.57% to $2.06, before settling in for the price of $1.83 at the close. Taking a more long-term approach, OKUR posted a 52-week range of $1.70-$20.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 4.41%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 68.85%. This publicly-traded company’s shares outstanding now amounts to $12.76 million, simultaneously with a float of $8.60 million. The organization now has a market capitalization sitting at $27.83 million. At the time of writing, stock’s 50-day Moving Average stood at $3.4700, while the 200-day Moving Average is $10.2000.
OnKure Therapeutics Inc (OKUR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. OnKure Therapeutics Inc’s current insider ownership accounts for 36.32%, in contrast to 63.38% institutional ownership. According to the most recent insider trade that took place on May 12 ’25, this organization’s 10% Owner sold 24,300 shares at the rate of 1.99, making the entire transaction reach 48,236 in total value, affecting insider ownership by 1,813,439. Preceding that transaction, on Apr 07 ’25, Company’s President and CEO sold 516 for 2.67, making the whole transaction’s value amount to 1,378. This particular insider is now the holder of 3,682 in total.
OnKure Therapeutics Inc (OKUR) Earnings and Revenue Records
OnKure Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 68.85% and is forecasted to reach -3.44 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 41.01% through the next 5 years, which can be compared against the 4.41% growth it accomplished over the previous five years trading on the market.
OnKure Therapeutics Inc (NASDAQ: OKUR) Trading Performance Indicators
Let’s observe the current performance indicators for OnKure Therapeutics Inc (OKUR). It’s Quick Ratio in the last reported quarter now stands at 11.17. The Stock has managed to achieve an average true range (ATR) of 0.25.
In the same vein, OKUR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.84, a figure that is expected to reach -1.26 in the next quarter, and analysts are predicting that it will be -3.44 at the market close of one year from today.
Technical Analysis of OnKure Therapeutics Inc (OKUR)
[OnKure Therapeutics Inc, OKUR] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 23.76% While, its Average True Range was 0.2400.
Raw Stochastic average of OnKure Therapeutics Inc (OKUR) in the period of the previous 100 days is set at 4.67%, which indicates a major fall in contrast to 37.89% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 80.96% that was higher than 73.14% volatility it exhibited in the past 100-days period.
